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DifferentiationThe present study explored the involvement of miR-302a in adipocyte differentiation via interaction
with 30-untranslated region of peroxisome proliferator-activated receptor gamma (PPARc) mRNA.
In differentiating 3T3-L1 adipocytes, expression of miR-302a was negatively correlated with that
of the adipogenic gene aP2 and PPARc. Overexpression of miR-302a inhibited adipogenic differen-
tiation with lipid accumulation, and inversely anti-miR-302a increased the differentiation. In silico
analysis revealed a complementary region of miR-302a seed sequence in 30-UTR of PPARc mRNA.
Luciferase assay showed the direct interaction of miR-302a with PPARc at the cellular level. The
miR-302a inhibition of adipocyte differentiation was reversed by PPARc overexpression. These ﬁnd-
ings suggest that miR-302a might be a negative regulator of adipocyte differentiation and that the
dysregulation of miR-302a should lead to metabolic disorders.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ing pathway involving regulated changes in the expression andAdipogenesis is a differentiation process for the formation of fat
cells from pre-adipocytes, and mature adipocytes are a major
depot for fat storage in healthy individuals [1]. Dysfunctions in adi-
pocyte tissue may cause health problems, such as obesity and type
II diabetes mellitus [2,3]. To understand obesity and its associated
diseases, it is important to elucidate the molecular mechanisms
governing adipogenesis.
Adipogenesis is typically described in the context of two major
phases: the determination phase and the terminal differentiation
phase [4,5]. In the determination phase, pluripotent MSCs are com-
mitted to become adipocyte precursor cells and lose their ability to
differentiate into other lineage cells, and these cells then differen-
tiate into pre-adipocytes, which are morphologically indistinguish-
able from their precursors. During the terminal phase, ﬁbroblastic
pre-adipocytes are converted to spherical mature adipocytes that
can synthesize and transport lipids and secrete adipocyte-speciﬁc
proteins to produce the adipocyte phenotype, and that contain
the machinery necessary for insulin sensitivity [6]. These processes
are mainly controlled by a complex and well-orchestrated signal-activity of several transcription factors, including peroxisome pro-
liferator-activated receptor gamma (PPARc) and CCAAT/enhance-
binding proteins (C/EBPs). In the early stage of adipogenic commit-
ment, C/EBPb and C/EBPd induce PPARc, which is a master regula-
tor of adipogenesis and C/EBPa, proceed to guide the cells toward
an adipogenic phenotype through the activation of target genes
including adiponectin, lipoprotein lipase, and adipocyte protein 2
(aP2) [7,8]. Therefore, transcription factors inﬂuence adipocyte
development and differentiation; emerging evidence suggests that
the post-transcriptional regulation of gene expression also has a
pivotal role in the same events.
MicroRNAs (miRNAs) are small, non-coding, single-stranded
RNAs of approximately 20–25 nucleotides that regulate gene
expression at the transcriptional level by speciﬁcally binding to
the 30-untranslated region (30-UTR) of target mRNA and control cel-
lular function including embryonic development, organ morphol-
ogy, cell proliferation and differentiation [9,10]. MiRNAs exert
essential regulatory functions in adipocyte differentiation as one
post-transcriptional modiﬁcation [9]. A number of recent studies
have revealed that miRNAs play crucial roles in adipogenesis. For
example,miR-27andmiR-130havebeen reported to inhibit adiopo-
genesis by targeting PPARc expression [11,12]. MiR-448 and miR-
15a have been reported to be repressors of adipogenesis due to the
inhibiting Kruppel-like factor 5 [13], whereas other miRNAs, such
asmiR-103 andmiR-143, can accelerate adipogenesis [14,15]. How-
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investigation.
The miR-302 gene encodes a cluster of eight miRNAs (miR-
302b⁄, -b, -c⁄, -c, -a⁄, -a, -d, -367) that are speciﬁcally expressed
in human embryonic stem cells and embryonal tumor cells [16].
MiR-302a has been implicated in the regulation of lipid metabo-
lism [17]. The expression of miR-302a in the liver is associated
with hepatic cholesterol, fatty acid and glucose metabolism [18].
More recently, miRNA microarray analysis showed that expression
level of miR-302a was downregulated during adipocytic differenti-
ation of 3T3-L1 cells [19]. Although miR-302a is regarded as a rel-
evant regulator for lipid metabolism, potential roles in
adipogenesis have not yet been demonstrated. Thus, we hypothe-
size that miR302a may be involved in regulating adipogenesis.
In the present study, we investigated effects of miR-302a on
adipocyte differentiation and characterized it as a negative regula-
tor of adipogenesis. Furthermore, we identiﬁed PPARc as the target
of miR-302a, proposing a regulatory mechanism in which
miR302a/PPARc controls adipogenesis. Our results shed new light
on the roles of miRNAs in adipocyte differentiation.
2. Materials and methods
2.1. Materials and reagents
Oligonucleotides [pri-miR negative control (miR-CTL), anti-miR
negative control (anti-miR-CTL), pri-miR-302a precursor (miR-
302a), and miR-302a inhibitor (anti-miR-302a)] and mirVana miR-
NA isolation kit were purchased from Ambion (Austin, TX, USA).
Ncode miRNA ﬁrst-strand cDNA synthesis kits and Lipofectamine
RNAiMAX were from Invitrogen (Carlsbad, CA, USA). pmirGLO
dual-luciferase miRNA target expression vector was obtained from
Promega (Madison, WI, USA). pcDNA3-PPARc plasmid was a kind
gift of Dr. H.S. Choi (Chonnam National University, Korea).
2.2. Animals
Male C57BL/6J mice were obtained from Daehan Biolink (Eums-
eong, Korea) and used under the guidelines of the Chonnam
National University Animal Care and Use Committee. At 12 weeks
of age, epididymal and inguinal white fats, representative of vis-
ceral and subcutaneous adipose tissue, respectively, were surgi-
cally isolated aseptically from three mice. The isolated tissues
were washed with phosphate-buffered saline (PBS), quickly frozen
in liquid nitrogen, and then stored at 80 C until analysis.
2.3. Cell cultures
3T3-L1 pre-adipocytes were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM; GIBCO-BRL, Grand Island, NY, USA) con-
taining 10% fetal calf serum (FCS; GIBCO-BRL) and antibiotics
(100 U/mL penicillin and 100 lg/mL streptomycin; GIBCO-BRL).
To induce adipocytic differentiation, cells were exposed to an adi-
pogenic medium containing 0.5 mM 3-isobutyl-methylxanthine,
1 lM dexamethasone and 1 lg/ml insulin for 2 days. The medium
was replaced with a fresh complete medium containing insulin,
and the cells were incubated for another 2 days. Thereafter, until
the cells were fully differentiated, they were maintained in 10%
FBS-DMEM with change of medium every other day.
2.4. RNA extraction and quantitative real-time polymerase chain
reaction (qRT-PCR)
Total RNA was extracted from the above tissues and cells using
Trizol reagent (Invitrogen). One microgram of total RNA was used
for cDNA preparation and was reverse transcribed using a reversetranscriptase kit (Invitrogen) according to the manufacturer’s
instructions. To quantify gene expression, qRT-PCR was performed
using TaqMan™ probes using TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, CA, USA) in the StepOnePlus
Real-Time PCR System (Applied Biosystems). Unlabelled speciﬁc
primers and the TaqMan probes were purchased from Applied Bio-
systems for detecting the FABP4 (aP2) gene, adiponectin gene, and
PPARc gene. The thermal cycling conditions were as follows:
15 min at 95 C, followed by 45 cycles of 95 C for 10 s, 55 C for
15 s and 72 C for 30 s. Relative expression was analyzed using
the 2DDCt method, and normalized to an endogenous control
18S gene. For analysis of microRNAs expression, qRT-PCR was per-
formed with NCode VILO miRNA cDNA synthesis kit (Invitrogen)
and Express SYBR GreenER™ miRNA qRT-PCR kit (Invitrogen).
The relative expression of miR-302 family was also analyzed using
the 2DDCt method, and normalized with snoRNA234. The PCR pri-
mer sequences used in the study were: miR-302a forward,
GCAAGTGCTTCCATGTTTTGGTGA; snoRNA234 forward,
GCGCGGAACTGAATCTAAGTGATTTAACAA. The miRNA-universal
reverse primer supplied in the NCode VILO miRNA cDNA synthesis
kit was used for reverse primers.
2.5. Oil Red O staining
3T3-L1 cells were transfected with miR-302a precursors or anti-
miR-302a using Lipofectamin RNAiMAX (Invitrogen), and cultured
in the adipogenic medium for 6 days. After washing with PBS, the
cells were ﬁxed with 4% formalin in PBS for 30 min and then
reacted with 60% saturated Oil Red O dye (Sigma, St. Louis, MI,
USA) for 20 min. Oil Red O-stained lipid droplets was photo-
graphed by LSM microscopy (Carl Zeiss, Oberkochen, Germany).
To quantify the degree of lipid droplet formation, the stained cells
were incubated with 99% isopropanol to extract the dye from lipid
droplets. The absorbance of reaction solution was measured at a
wavelength of 510 nmwith a microplate reader (Bio-Rad Laborato-
ries, Hercules, CA, USA).
2.6. Western blot analysis
Total cell extracts were harvested in a lysis buffer (Cell Signaling
Technology, Danvers, MA, USA) and centrifuged at 12,000g for
15 min at 4 C. Quantiﬁcation of total protein was performed using
the BCA protein assay reagent (Bio-Rad Laboratories). Proteinswere
resolved by 10% SDS–PAGE and transferred to a PVDF membrane.
After blocking in 5% milk in Tris-buffered saline with 0.1% Tween-
20, the membrane was incubated with speciﬁc primary antibodies
for PPARc (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and actin (1:2000, Cell Signaling Technology). Signalswere detected
by using an enhanced chemiluminescence reagent (Santa Cruz Bio-
technology). Densitometric analysis was conducted with LAS-4000
luminoimage analyzer system (Fujiﬁlm, Tokyo, Japan).
2.7. Dual luciferase assays
PPARc mRNA has a putative miR-302a binding sequences
(UCGUGAAU) in the 30-UTR region (TargetScan, http://www.target-
scan.org/). To identify the interaction with PPARc and miR-302a,
dual luciferase assays was performed with a vector containing
miRNA target sequence. To construct the 30-UTR-luciferase repor-
ter, the 30-UTR of PPARc gene was ampliﬁed using the following
primers; for wild type, forward 50-AAAGAGCTCCAGGAAAGTCCCA
CCCGCTGA-30 and reverse 50-TTTCTCGAGGATGGCAGAATGGGAG
ACAT-30; for mutant type, forward 50-ACTGTGAAATTCGATTTA
AAAAC-30 and reverse 50-GTTTTTAAATCGAATTTCACAGT-30 The
cDNA product was transferred into the pmirGLO dual-luciferase
miRNA target expression vector (Promega). Mutant form of 30-UTR
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the same vector. The correct orientation and nucleotide sequence
of 30-UTR fragments in the construct was further conﬁrmed by
sequencing analysis. The 3T3-L1 cells were co-transfected with
0.5 lg of the reporter vectors (pmirGLO, pmirGLO-PPARc-30-UTR-
WT or pmirGLO-PPARc-30-UTR-Mut) and 30 nM miR-302a precur-
sor or 30 nM miR-control using Lipofectamine 2000. Forty-eight
hours after transfection, ﬁreﬂy and renilla luciferase activities were
determined using the Dual-Glo luciferase assay system (Promega).
2.8. Statistical analysis
All experiments were repeated at least three times. Results are
expressed as mean ± S.D. Statistical signiﬁcance was evaluated by
two-tailed Student’s t-test, and a P-value of <0.05 was considered
signiﬁcant.
3. Results
3.1. Expression of miR-302a is decreased during adipocyte
differentiation
A recent study of miRNA proﬁles in hepatocytes implicated
miR-302a in the regulation of lipid metabolism [17]. Presently,Fig. 1. Expression of miR-302a is decreased in adipocyte differentiation. (A) Expression p
epididymal (visceral) and inguinal (subcutaneous) fat pads of 12-week-old mice and qRT-
against sno234, expressions of miR-302 family were compared relative to that of miR-30
denotes subcutaneous adipose tissue and VAT denotes visceral adipose tissue. (B) Express
were cultured with adipogenic medium for 48 h. The expression of miR-302s was deter
compared with that of miR-302a at day 0. All results represent mean ± SD (n = 3). ⁄P <
differentiation. 3T3-L1 cells were cultured with adipogenic medium for the indicated
identiﬁed by qRT-PCR. After normalizing against sno234 or b-actin, their expressions at th
(n = 3). ⁄P < 0.05 compared with day 0.the role of miR-302a in adipocyte differentiation was examined.
Expression levels of miR-302 family members in white adipose tis-
sues of mice and pre-adipocyte 3T3-L1 cells were examined.
Expression of miR-302a was lowest in epididymal and inguinal
white adipose tissues of mice and differentiating 3T3-L1 cells,
which were induced by 3-isobubutyl-methylxanthine, dexametha-
sone, and insulin (Fig. 1A and B).
To conﬁrm the changes of miR-302a expression during adipo-
cyte differentiation, the levels of miR-302a at various times during
differentiation were examined. The adipogenic stimuli time-
dependently increased the expression of adipocyte-speciﬁc aP2
and PPARcmRNA, which are required for adipocyte differentiation,
and signiﬁcantly decreased miR-302a expression for 4 days. How-
ever, on day 6 after induction the miR-302a expression was consid-
erably recovered (Fig. 1C). These results suggested that miR-302a
might potently inhibit adipogenesis.
3.2. MiR-302a governs lipid droplet formation and adipocyte-speciﬁc
gene expression
To determine the role of miR-302a in adipogenic differentiation,
gain- and loss-of-function experiments were performed. When
3T3-L1 cells were transfected with miR-302a precursor or control
microRNA, the level of endogenous miR-302a was signiﬁcantlyroﬁles of miR-302 family in white adipose tissues. Total RNA was isolated from the
PCR was performed to examine the expression of miR-302 family. After normalizing
2a. All results represent mean ± SD (n = 3). ⁄P < 0.05 compared with miR-302a. SAT
ion proﬁles of miR-302 family during adipogenic differentiation of 3T3-L1 cells. Cells
mined by qRT-PCR. The expressions were normalized against those of sno234, and
0.05 compared with day 0. (C) Time-course expression of miR-302a in adipogenic
time. Expression of miR-302a and adipocyte-speciﬁc genes (aP2 and PPARc) was
e indicated time were compared with that at day 0. All results represent mean ± SD
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duction of miR-302a inhibited lipid droplet formation in response
to adipogenic medium, as evidenced by Oil Red O staining (Fig. 2B).
Consistently, the overexpression of miR-302a elicited marked
decreases in the expression of adipogenic markers including aP2,
adiponectin, and PPARc at day 4, compared to the control group
(Fig. 2C).
On the other hand, transfection of anti-miR-302a decreased the
miR-302a expression in 3T3-L1 cells (Fig. 3A). Lipid droplet forma-
tion was signiﬁcantly enhanced upon expression of anti-miR-302a,
evidenced by Oil Red O-positive adipocytes (Fig. 3B). Consistent
with these results, the expression levels of aP2, adiponectin, and
PPARc mRNA were all up-regulated after inactivation of miR-
302a by anti-miR-302a transfection (Fig. 3C). The results indicate
that miR-302a might govern the adipogenic differentiation by
controlling the adipocyte-speciﬁc gene expression.
3.3. MiR-302a speciﬁcally inhibits PPARc protein expression by
targeting 30-UTR of PPARc mRNA
To clarify the molecular mechanisms underlying miR-302a reg-
ulation of adipogenesis, we searched for miR-302a targets using a
computational miRNA target prediction analysis with several dat-
abases (http://www.targetscan.org and http://www.microrna.org).
The search revealed a putative binding sequence for miR-302a in
the 30-UTR of PPARc, a major transcriptional regulator of adipocyte
differentiation. To further determine whether miR-302a directlyFig. 2. Overexpression of miR-302a suppresses adipocyte differentiation. 3T3-L1 cells we
adipogenic medium for an additional 6 days. (A) Expressional efﬁciency of miR-302a was
by Oil Red O staining at day 6 of the culture (left panel). For quantiﬁcation, lipid-bound O
a plate reader at 510 nm (right panel). (C) The expression level of adipogenic markers. T
speciﬁc primers for aP2, adiponectin, and PPARc. All results represent mean ± SD (n = 3)targeted the 30-UTR of PPARc mRNA, pmirGLO 30-UTR luciferase
reporter plasmids containing putative binding sequences for
miR-302a or mutant PPARc-30-UTR were synthesized, in which
four nucleotides were changed to disrupt the putative interaction
between PPARc mRNA and miR-302a (Fig. 4A). Consistent with
the bioinformatic prediction, the co-transfection of miR-302a with
a wild type reporter (pmirGLO-PPARc-30-UTR-WT) resulted in a
highly signiﬁcant decrease in luciferase activity in 3T3-L1 cells,
compared with the control group (Fig. 4B). No decrease in lucifer-
ase activity was observed when miR-302a was co-transfected with
the empty vector or mutant reporter (pmirGLO-PPARc-30-UTR-
Mut), indicating that the predicted site is a direct target of miR-
302a. To examine whether or not the miR-302a could regulate
the expression of PPARc, the PPARc protein level was measured
using Western blotting in the 3T3-L1 cells transiently transfected
with miR-302a or anti-miR-302a. Overexpression of miR-302a sig-
niﬁcantly reduced PPARc protein levels at day 4 in the 3T3-L1 cells
(Fig. 4C and D), while endogenous inhibition of miR-302a elevated
the protein level of PPARc (Fig. 4E and F). These results suggested
that miR-302a could negatively regulate PPARc expression
through direct binding to the 30-UTR of PPARc.
3.4. Overexpression of PPARc reverses miR-302a inhibition of
adipogenic differentiation
The above data suggested that PPARc is a direct target of miR-
302a. We additionally examined whether the constitutive expres-re transfected with miR-CTL (30 nM) or miR-302a (30 nM) for 24 h and treated with
examined by qRT-PCR. (B) Formation of intracellular lipid droplets was determined
il Red O was extracted with isopropyl alcohol and then absorbance was measured in
otal RNAs were isolated from the cultured cells and qRT-PCR was performed with
. ⁄P < 0.05 compared with miR-CTL.
Fig. 3. Inhibition of miR-302a enhances adipocyte differentiation. 3T3-L1 cells were transfected with anti-miR-302a (100 nM) or anti-miR-CTL (100 nM) for 24 h and then
treated with adipogenic medium for an additional 6 days. (A) qRT-PCR analysis was performed to determine the endogenous inhibition of the miR-302a. (B) Oil Red O staining
was performed to determine effects of anti-miR-302a on lipid droplet formation at day 6 of the culture (left panel). For quantiﬁcation, lipid-bound Oil Red O was extracted
with isopropyl alcohol and absorbance was measured at 510 nm (right panel). (C) The expression level of adipogenic markers was measured by qRT-PCR. All results represent
mean ± SD (n = 3). ⁄P < 0.05 compared with anti-miR-CTL.
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Overexpression of PPARc occurred due to transient transfection,
as evidenced by the raised expression of PPARc mRNA evident in
RT-PCR (Fig. 5A). Oil Red O staining showed that the supplementa-
tion of PPARc reversed the inhibitory effect of miR-302a on adipo-
cyte differentiation (Fig. 5B, left panel). Quantitative analysis
conﬁrmed a signiﬁcant increase of lipid droplets (Fig. 5B, right
panel). In addition, overexpression of PPARc also attenuated the
miR-302a inhibition of adipocyte-speciﬁc gene expression
(Fig. 5C). These results reconﬁrmed that miR-302a could negatively
regulate the adipogenic differentiation partly by inhibiting PPARc
expression.
4. Discussion
This study identiﬁes miR-302a as a novel negative regulator of
adipocyte differentiation whose effect is mediated, at least in part,
by its potent repression of PPARc. A growing body of evidence indi-
cates miRNAs play critical roles in both normal biological processes
and the pathogenesis of human diseases by post-transcriptionally
regulating gene expression [20,21]. Furthermore, miRNAs can form
extensive regulatory networks with a complexity comparable to
that of transcription factors [22].
The miR-302a family is emerging as a key player in the control
of proliferation and in cell fate determination during differentia-
tion [23–25]. Although the mature miRNA sequence of all mem-
bers of the miR-302 family share a common 8-mer conservedseed sequence, they are differentially expressed and regulate bio-
logical processes. MiR-302a appears to control the reprogramming
of somatic cells via the repression of NR2F2 (COUP-TFII) [26].
NR2F2 plays an essential role in adipogenesis, glucose homeostasis,
and energy metabolism [27], and the depletion of NR2F2 inhibits
adipogenesis from mesenchymal cells [28]. Accordingly, miR-
302a has also been implicated in the regulation of lipid metabolism
[17] and glucose metabolism [29]. In addition, it is interesting to
note that expression of miR-302a during adipogenic process was
down-regulated in miRNA microarray analysis [19].
Our study demonstrates for the ﬁrst time that miR-302a can
functionally alleviate adipocyte differentiation of 3T3-L1. In the
cell culture experiments with adipogenic medium, the expression
levels of miR-302a decreased at 2 days and were further markedly
decreased at 4 days. However, the level of miR-302a at 6 days was
recovered to a 75% level of control group (day 0) (Fig. 1C). Consid-
ering previous studies that adipocyte differentiation is initiated
with the increase of PPARc and C/EBPa expression [30] and that
major change of miRNA expressions occur as early as days 2–4
[31], miR-302a appears to be involved in the functional control
of the early stage rather than that of late terminal stage.
In the present study, we also examined the expression of miR-
302 family in epididymal and inguinal white fat in 12-week-old
male mice (Fig. 1A). MiR-302a expression was relatively low in
both tissues compared to other miR-302 family, suggesting that
miR-302a might have more critical roles than other miR-302 fam-
ily members. MiR-302a expression appeared to be suppressed for a
Fig. 4. MiR-302a inhibits PPARc protein expression by targeting 30-UTR of PPARcmRNA. (A) Schematic diagram of miR-302a target sequence in the 30-UTR of mouse PPARc
mRNA and its mutated version. (B) The pmirGLO, pmirGLO PPARc-30-UTR-WT or pmirGLO PPARc-30-UTR-Mut vector was co-transfected with miR-302a or miR-CTL into 3T3-
L1 cells, and the luciferase assay was performed. (C, D) 3T3-L1 cells were transfected with transfected with miR-302a or miR-CTL for 24 h and then treated with adipogenic
medium for an additional 4 days. Western blotting analysis (C) and densitometric analysis (D) were performed to examine PPARc protein levels. The levels were normalized
to b-actin loading control. The values represent mean ± SD (n = 3). ⁄P < 0.05. (E, F) 3T3-L1 cells were transfected with anti-miR-302a or anti-miR-CTL for 24 h, and then treated
with adipogenic medium for additional 4 days. The expression of PPARc protein was evaluated by Western blotting analysis (E) and densitometric analysis (F). PPARc protein
levels were normalized to b-actin loading control. The values represent mean ± SD (n = 3). ⁄P < 0.05.
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sion. However, the results did not provide direct evidence that
miR-302a was still suppressed up to 12 weeks or recovered with
ﬁnal differentiation of fat cells in the white fat tissues as in the dif-
ferentiating 3T3-L1 cells. To exactly understand the role of miR-
302a in the formation of fat tissues, more extensive study withdata from various times in normal or high-fat diet-fed mice is
needed.
In the study, gain- or loss-of-function studies were performed
to delineate the precise roles of miR-302a in adipocyte differentia-
tion. MiR-302a precursor blocked the formation of adipocytes
(Fig. 2). Conversely, endogenous inhibition of miR-302a enhanced
Fig. 5. Overexpression of PPARc reverses miR-302a suppression of adipogenic differentiation. 3T3-L1 cells were co-transfected with miR-302a (30 nM) and pcDNA3-PPARc
plasmid (100 ng), and cultured with adipogenic medium for an additional 6 days. (A) Expression efﬁciency of pcDNA3-PPARc plasmid was conﬁrmed by RT-PCR.
Abbreviations: EV, empty vector; pcDNA3. (B) Cells were stained with Oil Red O solution and intracellular lipid droplets were photographed (left panel). For quantiﬁcation,
lipid-bound Oil Red O staining was extracted with isopropyl alcohol and then absorbance was measured at 510 nm (right panel). All results represent mean ± SD (n = 3).
⁄P < 0.05. (C) Expression level of adipogenic markers. Total RNAs were isolated from the cultured cells, and qRT-PCR was performed with speciﬁc primers for aP2, adiponectin,
and PPARc. All results represent mean ± SD (n = 3). ⁄P < 0.05.
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strong evidence that miR-302a might negatively regulate adipo-
cyte differentiation.
MiRNAs can regulate adipocyte differentiation by targeting
diverse signaling molecules and pathways. To study the molecular
mechanism by which miR-302a regulates adipocyte differentia-
tion, we analyzed the potential targets with the assistance of pre-
diction programs. PPARcwas predicted to be a putative target with
the seven consecutive nucleotides match site, complementary to
miR-302a (Fig. 4A). MiR-302a overexpression suppressed the cellu-
lar level of PPARc protein, whereas the functional inhibition of
miR-302a led to the elevation of PPARc expression; these observa-
tions strongly suggest that PPARc is regulated by miR-302a
(Fig. 4C–F). The dual luciferase reporter assay also identiﬁed PPARc
as a direct target of miR-302a (Fig. 4B). Supplementation of PPARc
could also partly attenuate the suppressive effect of miR-302a on
adipocyte differentiation and accumulation of lipid droplets
(Fig. 5). These results suggest that miR-302a might negatively reg-
ulate adipogenic differentiation partly by targeting PPARc mRNA.
There are some differences in adipocyte functions between sub-
cutaneous and visceral white fats concerning their relevancy to
metabolic diseases including obesity, type II diabetes and insulin
resistance, and expression of speciﬁc genes [32,33]. We observed
no signiﬁcant change in the expression levels of miR-302 family
between subcutaneous inguinal and visceral epididymal fat in
mice fed a normal diet, indicating that miR-302a might have a role
in regulating adipogenesis through a common pathway regardless
of the type of fat tissue. However, to better understand the exact
role of miR-302a in adiposity, studies are needed in various path-
ologic animals relating to obesity (high fat diet), diabetes and insu-
lin resistance.
In summary, a series of ﬁndings provide evidence that miR-
302a might be a novel negative regulator of PPARc and serve as
a suppressor of adipogenic differentiation. Therefore, miR-302a is
an attractive target for new therapies aimed at reducing excess
fat tissue.Conﬂict of interest
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